Why the study?
Tissue specificity of mitochondrial diseases may rely on tissue-specific capacities to compensate for mitochondrial defects, contributing to phenotypic heterogeneity.
Identical primary mitochondrial defects can lead to vastly different phenotypic outcomes, such as severe dilated cardiomyopathy versus minimal skeletal muscle damage, depending on tissue-specific capacities for metabolic remodelling and stress response.
Answers are grounded in this paper and cite their sources.
Tissue-specific compensation may drive mitochondrial disease heterogeneity; leaves open relevance to human patients.
It becomes increasingly clear that the tissue specificity of mitochondrial diseases might in part rely on their ability to compensate for mitochondrial defects, contributing to the heterogeneous nature of mitochondrial diseases. Here, we investigated tissue-specific responses to cytochrome c oxidase (CIV or COX) deficiency using a mouse model with heart and skeletal muscle-specific depletion of the COX assembly factor COX10. At three weeks of age, both tissues exhibit pronounced CIV depletion but respond differently to oxidative phosphorylation (OXPHOS) impairment. Heart-specific COX10 depletion caused severe dilated cardiomyopathy, while skeletal muscle experiences less damage. Cardiac CIV deficiency triggered extensive metabolic remodelling and stress response activation, potentially worsening cardiomyopathy, whereas skeletal muscle showed no stress response or significant metabolic changes. Our findings highlight distinct tissue capacities for managing CIV deficiency, explaining how identical primary defects can lead to different phenotypic outcomes and contribute to the heterogeneous progression of mitochondrial diseases.
No takes yet. Share an insight, caveat, or question.
Popović et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: